The purpose of this study is to assess the efficacy and safety of a cashew apple extract on weight management and associated metabolic risk factors in overweight/obese volunteers, versus placebo, after 12 weeks of treatment.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Enrollment
66
6 capsules per day (2 capsules 3 times per day, to be taken before breakfast, lunch and diner, each capsule containing 200 mg of Cashewin) during 12 weeks
6 capsules per day (2 capsules 3 times per day, to be taken before breakfast, lunch and diner) during 12 weeks
Clinical Nutrition Center Naturalpha (CNCN)
Lille, France
RECRUITINGBody weight reduction
Time frame: 12 weeks
Body weight variation
Time frame: 6 weeks and 12 weeks
Body fat variation
Time frame: 6 and 12 weeks
BMI variation
Time frame: 6 and 12 weeks
Waist and hip circumferences variation
Time frame: 6 and 12 weeks
Fasting glycemia variation
Time frame: 12 weeks
Fasting insulinemia variation
Time frame: 12 weeks
HOMA-IR index variation
Time frame: 12 weeks
Variation of glycemia 2h post glucose solution intake
Time frame: 12 weeks
Blood lipids (total cholesterol, HDL, LDL, triglycérides) variation
Time frame: 12 weeks
CRPus variation
Time frame: 12 weeks
Systolic and diastolic blood pressure variation
Time frame: 6 and 12 weeks
Safety (blood parameters measurements: urea, creatinine, ASAT, ALAT) with adverse events recording
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: 12 weeks